Shaker Investments LLC Supernus Pharmaceuticals, Inc. Transaction History

Shaker Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 28, 2019	SELL	$25.47 - $33.37 $738,757 - $967,896	-29,005 Closed	0 $0
Q2 2019 Aug 07, 2019	SELL	$29.96 - $38.87 $1.01 Million - $1.32 Million	-33,835 Reduced 53.84%	29,005 $960,000
Q1 2019 May 06, 2019	SELL	$32.77 - $41.99 $4,325 - $5,542	-132 Reduced 0.21%	62,840 $2.2 Million
Q4 2018 Feb 06, 2019	BUY	$30.84 - $49.51 $411,868 - $661,206	13,355 Added 26.92%	62,972 $2.09 Million
Q3 2018 Oct 30, 2018	SELL	$42.7 - $56.55 $1,067 - $1,413	-25 Reduced 0.05%	49,617 $2.5 Million
Q2 2018 Jul 30, 2018	BUY	$44.1 - $59.85 $308,788 - $419,069	7,002 Added 16.42%	49,642 $2.97 Million
Q1 2018 May 02, 2018	BUY	$37.15 - $46.9 $1.58 Million - $2 Million	42,640 New	42,640 $1.95 Million

279

60.6M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.01B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Shaker Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Shaker Investments LLC with notifications on news.